Downregulation of ACSL5 could be an independent prognostic factor for early recurrence of colorectal cancer [69], meanwhile dysregulated ALAS2 expression was related to the risk of acute myeloid leukemia [70]. Here, ACSL5 is linked to colorectal cancer.